SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

世界の自己免疫疾患治療法市場：規模、予測、COVID-19の影響分析（2021-2025年）

世界の自己免疫疾患治療法市場：規模、予測、COVID-19の影響分析（2021-2025年）Global Autoimmune Disease Therapeutics Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)

このレポートへお問合せ

  
種別英文調査報告書
出版Daedal Research
出版年月2021年2月
ページ数82
図表数
価格（USD）
シングルユーザライセンス900
エンタープライズライセンス1500
 

レポート目次

  Report DetailsScope of the ReportThe report titled “Global Autoimmune Disease Therapeutics Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)”, provides an in depth analysis of the global autoimmune disease therapeutics market by value, by drug class, by indication, by region, etc. The report provides a regional analysis of the autoimmune disease therapeutics market, including the following regions: North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. The report also provides a detailed analysis of the COVID-19 impact on the autoimmune disease therapeutics market.The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global autoimmune disease therapeutics market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.The global autoimmune disease therapeutics market is fragmented with many major market players operating worldwide. The key players of the autoimmune disease therapeutics market are Roche Holding AG, Pfizer Inc., Johnson & Johnson, and Abbott Laboratories are also profiled with their financial information and respective business strategies.Country CoverageNorth AmericaEuropeAsia PacificMiddle East & AfricaLatin AmericaCompany CoverageRoche Holding AGPfizer Inc.Johnson & JohnsonAbbott LaboratoriesExecutive SummaryAn autoimmune disease is a condition in which the body’s immune system attacks and destroys healthy cells and tissues in the body by mistake. In other words, autoimmune disease arises when the immune system fails to distinguish between the body’s own cells and foreign cells. These diseases can affect any part of the body. Autoimmune disease therapeutics is a form of treatment to calm the overactive immune response, to limit tissue damage, and to reduce pain and inflammation. Treatment can also help in relieving symptoms like pain, swelling, and skin rashes.There are a lot of therapeutic alternatives available, but no option has a perfect safety profile. Infact, while some treatments have been effective in treating certain autoimmune disorders, no treatment is effective for all autoimmune diseases.The autoimmune disease therapeutics market can be segmented on the basis of drug class (Immunosuppressant’s, Anti-inflammatory Drug, Interferons, NSAIDs, Antihyperglycemics, and Others); indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes, Psoriasis, and Others); and distribution channel (Hospital & Clinics, Pharmacies, Drug Stores, Online Stores, and Others).The global autoimmune disease therapeutics market has increased significantly during the years 2018-2020 and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. The autoimmune disease therapeutics market is expected to increase due to rapid urbanization, escalating healthcare spending, rising prevalence of autoimmune diseases, favorable government initiatives, etc. Yet the market faces some challenges such as high cost involved, lack of approved treatment for IPF (Idiopathic Pulmonary Fibrosis), etc. Table of Contents

目次

1. Executive Summary2. Introduction2.1 Autoimmune Disease: An Overview2.1.1 Most Common Autoimmune Diseases2.1.2 Areas Affected by Autoimmune Diseases2.1.3 Common Autoimmune Disease Symptoms2.2 Autoimmune Disease Therapeutics: An Overview2.2.1 Evolution of Autoimmune Disease Treatment Depending on the Severity of the Disease2.3 Autoimmune Disease Therapeutics Segmentation: An Overview2.3.1 Autoimmune Disease Therapeutics Segmentation by Drug Class2.3.2 Autoimmune Disease Therapeutics Segmentation by Indication2.3.3 Autoimmune Disease Therapeutics Segmentation by Distribution Channel3. Global Market Analysis3.1 Global Autoimmune Disease Therapeutics Market: An Analysis3.1.1 Global Autoimmune Disease Therapeutics Market by Value3.1.2 Global Autoimmune Disease Therapeutics Market by Drug Class (Anti-inflammatory, Interferons, NSAIDs, Antihyperglycemics and Others)3.1.3 Global Autoimmune Disease Therapeutics Market by Indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes and Other Indications)3.1.4 Global Autoimmune Disease Therapeutics Market by Region (North America, Europe, Asia Pacific, Middle East & Africa and Latin America)3.2 Global Autoimmune Disease Therapeutics Market: Drug Class Analysis3.2.1 Global Anti-Inflammatory Autoimmune Disease Therapeutics Market by Value3.2.2 Global Interferons Autoimmune Disease Therapeutics Market by Value3.2.3 Global NSAIDs Autoimmune Diseases Therapeutics Market by Value3.2.4 Global Antihyperglycemics Autoimmune Disease Therapeutics Market by Value3.2.5 Global Others Autoimmune Disease Therapeutics Market by Value3.3 Global Autoimmune Disease Therapeutics Market: Indication Analysis3.3.1 Global Rheumatoid Arthritis Therapeutics Market by Value3.3.2 Global Type 1 Diabetes Therapeutics Market by Value3.3.3 Global Multiple Sclerosis Therapeutics Market by Value3.3.4 Global Inflammatory Bowel Disease Therapeutics Market by Value3.3.5 Global Other Indications Therapeutics Market by Value4. Regional Market Analysis4.1 North America Autoimmune Disease Therapeutics Market: An Analysis4.1.1 North America Autoimmune Disease Therapeutics Market by Value4.2 Europe Autoimmune Disease Therapeutics Market: An Analysis4.2.1 Europe Autoimmune Disease Therapeutics Market by Value4.3 Asia Pacific Autoimmune Disease Therapeutics Market: An Analysis4.3.1 Asia Pacific Autoimmune Disease Therapeutics Market by Value4.4 Middle East & Africa Autoimmune Disease Therapeutics Market: An Analysis4.4.1 Middle East & Africa Autoimmune Disease Therapeutics Market by Value4.5 Latin America Autoimmune Disease Therapeutics Market: An Analysis4.5.1 Latin America Autoimmune Disease Therapeutics Market by Value5. Impact of COVID-195.1 Impact of COVID-195.1.1 Impact of COVID-19 on Healthcare Sector5.1.2 Impact of COVID-19 on Autoimmune Disease Therapeutics6. Market Dynamics6.1 Growth Driver6.1.1 Rapid Urbanization6.1.2 Escalating Healthcare Spending6.1.3 Rising Prevalence of Autoimmune Diseases6.1.4 Favorable Government Initiatives6.2 Challenges6.2.1 High Cost Involved6.2.2 Lack of Approved Treatment for IPF (Idiopathic Pulmonary Fibrosis)6.3 Market Trends6.3.1 Innovations in the Treatment of Autoimmune Diseases6.3.2 Growing Adoption of JAK Inhibitors for the Treatment of Autoimmune Diseases6.3.3 Increasing Awareness among Patients towards the Autoimmune Diseases and Therapeutic Treatments7. Competitive Landscape7.1 Global Autoimmune Disease Therapeutics Market Players: A Financial Comparison7.2 Global Autoimmune Disease Therapeutics Market Players by Development of Drugs for IMIDs Targeting JAK8. Company Profiles8.1 Roche Holding AG8.1.1 Business Overview8.1.2 Financial Overview8.1.3 Business Strategy8.2 Pfizer Inc.8.2.1 Business Overview8.2.2 Financial Overview8.2.3 Business Strategy8.3 Johnson & Johnson8.3.1 Business Overview8.3.2 Financial Overview8.3.3 Business Strategy8.4 Abbott Laboratories8.4.1 Business Overview8.4.2 Financial Overview8.4.3 Business StrategyList of FiguresFigure 1: Most Common Autoimmune DiseasesFigure 2: Areas Affected by Autoimmune DiseasesFigure 3: Common Autoimmune Disease SymptomsFigure 4: Evolution of Autoimmune Diseases Treatment Depending on the Severity of the DiseaseFigure 5: Autoimmune Disease Therapeutics Segmentation by Drug ClassFigure 6: Autoimmune Disease Therapeutics Segmentation by IndicationFigure 7: Autoimmune Disease Therapeutics Segmentation by Distribution ChannelFigure 8: Global Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)Figure 9: Global Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)Figure 10: Global Autoimmune Disease Therapeutics Market by Drug Class; 2020 (Percentage, %)Figure 11: Global Autoimmune Disease Therapeutics Market by Indication; 2020 (Percentage, %)Figure 12: Global Autoimmune Disease Therapeutics Market by Region; 2020 (Percentage, %)Figure 13: Global Anti-Inflammatory Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)Figure 14: Global Anti-Inflammatory Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)Figure 15: Global Interferons Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)Figure 16: Global Interferons Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)Figure 17: Global NSAIDs Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)Figure 18: Global NSAIDs Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)Figure 19: Global Antihyperglycemics Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)Figure 20: Global Antihyperglycemics Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)Figure 21: Global Others Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)Figure 22: Global Others Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)Figure 23: Global Rheumatoid Arthritis Therapeutics Market by Value; 2018-2020 (US$ Billion)Figure 24: Global Rheumatoid Arthritis Therapeutics Market by Value; 2021-2025 (US$ Billion)Figure 25: Global Type 1 Diabetes Therapeutics Market by Value; 2018-2020 (US$ Billion)Figure 26: Global Type 1 Diabetes Therapeutics Market by Value; 2021-2025 (US$ Billion)Figure 27: Global Multiple Sclerosis Therapeutics Market by Value; 2018-2020 (US$ Billion)Figure 28: Global Multiple Sclerosis Therapeutics Market by Value; 2021-2025 (US$ Billion)Figure 29: Global Inflammatory Bowel Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)Figure 30: Global Inflammatory Bowel Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)Figure 31: Global Other Indications Therapeutics Market by Value; 2018-2020 (US$ Billion)Figure 32: Global Other Indications Therapeutics Market by Value; 2021-2025 (US$ Billion)Figure 33: North America Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)Figure 34: North America Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)Figure 35: Europe Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)Figure 36: Europe Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)Figure 37: Asia Pacific Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)Figure 38: Asia Pacific Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)Figure 39: Middle East & Africa Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)Figure 40: Middle East & Africa Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)Figure 41: Latin America Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)Figure 42: Latin America Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)Figure 43: Global Urbanization Rates by Region; 2010-2040 (Percentage, %)Figure 44: Global Healthcare Spending; 2017-2022 (US$ Billion)Figure 45: Global Prevalence of Diagnosed Autoimmune Conditions by Region; 2019 (Percentage, %)Figure 46: Roche Holding AG Sales; 2016-2020 (US$ Billion)Figure 47: Roche Holding AG Sales by Segments; 2020 (Percentage, %)Figure 48: Roche Holding AG Sales by Region; 2020 (Percentage, %)Figure 49: Pfizer Inc. Revenues; 2019-2020 (US$ Billion)Figure 50: Pfizer Inc. Revenues by Segments; 2020 (Percentage, %)Figure 51: Pfizer Inc. Revenues by Region; 2020 (Percentage, %)Figure 52: Johnson & Johnson Sales; 2015-2019 (US$ Billion)Figure 53: Johnson & Johnson Sales by Segments; 2019 (Percentage, %)Figure 54: Johnson & Johnson Sales by Region; 2019 (Percentage, %)Figure 55: Abbott Laboratories Net Sales; 2015-2019 (US$ Billion)Figure 56: Abbott Laboratories Net Sales by Segments; 2019 (Percentage, %)Figure 57: Abbott Laboratories Net Sales by Region; 2019 (Percentage, %)Table 1: Global Autoimmune Disease Therapeutics Market Players: A Financial Comparison; 2019/2020Table 2: Global Autoimmune Disease Therapeutics Market by Development of Drugs for IMIDs Targeting JAK

お問合せフォーム

    お問合せフォーム

    • *のある項目は必須項目です。

    • レポートのタイトルは自動で入ります。

    • 無料サンプルはご購入を検討されている方向けのレポート形式等確認用資料です。
      重要記述や数値は記載されていません。予めご了承ください。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com

    プライバシーポリシーはこちらをご覧ください。

    その他の最新記事8件